SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:
- Kevin Sayer, President and Chief Executive Officer, will present an update on the company at the Credit Suisse 25th Annual Healthcare Conference in Scottsdale, Arizona, on Tuesday, November 8, 2016, at 2:30 p.m. (MT). The presentation, which will occur live at The Phoenician Hotel, will be concurrently webcast.
- Jess Roper, Senior Vice President and Chief Financial Officer, and Matthew Dolan, Senior Director Corporate Affairs, will present an update on the company at the Stephens 2016 Fall Investment Conference in New York City, New York, on Wednesday, November 9, 2016, at 1:00 p.m. (ET). The presentation, which will occur live at The Lotte New York Palace Hotel, will be concurrently webcast.
The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.